{"database": "lobbying", "table": "lobbying_activities", "rows": [[2689595, "58cfb562-72f6-4181-927e-0a8f892e24da", "Q3", "SUMMIT PUBLIC AFFAIRS", 401105467, "VANDA PHARMACEUTICALS INC.", 2021, "third_quarter", "PHA", "Issues affecting the pharmaceutical industry, including the prescription drug approval process.\n21st Century Cures Act 2.0 (proposed legislation).", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2021-10-19T11:31:44.320000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2689595"], "units": {}, "query_ms": 59.509092941880226, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}